Civil Litigation
Jun. 13, 2022
Latham & Watkins LLP secures full dismissal for GoodRx in class action lawsuit
Latham & Watkins partner Michele D. Johnson said she was satisfied with Thursday’s decision
Latham & Watkins LLP obtained a full dismissal of a shareholder class action against GoodRx on Thursday.
The lawsuit, filed in 2018 in federal court in Los Angeles, accused the defendants of failing to disclose at the time of GoodRx’s 2020 IPO that Amazon.com would soon introduce a competing prescription drug fulfillment service.
In January, U.S. District Judge David O. Carter in Santa Ana granted GoodRx’s...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In